1 year return (CAGR)
2.45%
Neurocrine Biosciences Inc Exchange (NASDAQ, USD)
NBIX
146.23
-5.60 (-3.69%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
8.56%
5 year return (CAGR)
8.61%
10 year return (CAGR)
11.22%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
14.86B
Price/Sales
4.41
Ent value
16.20B
Price/Book
4.02
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
21.07
PEG
-
Forward P/E
12.23
EPS growth
2.31%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 152.63 |
| Daily high | 152.63 |
| Daily low | 146.06 |
| Daily Volume | 2.82M |
| All-time high | 185.50 |
| 1y analyst estimate | 211.57 |
| Beta | 0.39 |
| EPS (TTM) | 6.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 6 May 2026 |
Downside potential
Loading...
Downside potential data
| NBIX | S&P500 | |
| Current price drop from All-time high | -21.17% | -2.08% |
| Highest price drop | -97.21% | -56.47% |
| Date of highest drop | 12 Nov 2009 | 9 Mar 2009 |
| Avg drop from high | -43.48% | -10.68% |
| Avg time to new high | 59 days | 12 days |
| Max time to new high | 2931 days | 1805 days |
News
